Neumora Therapeutics, Inc. Common Stock (NMRA) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Neumora Therapeutics, Inc. Common Stock, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.23x | -6.93x | -11.48x | -18.86x | -10.40x | -24.87x |
| P/B Ratio | 2.82x | 5.89x | 5.77x | -5.53x | -7.59x | -26.16x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 5.87x | 10.51x | 19.05x | 16.37x | 17.85x | 20.69x |
| Quick Ratio | 5.87x | 10.51x | 19.05x | 16.37x | 17.85x | 20.69x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.01x | 0.01x | -0.02x | -0.01x | -0.02x |
YoY = year-over-year change. Source: FMP..